Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ADXS Stock Summary
Top 10 Correlated ETFs
ADXS
In the News
Advaxis to Present Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in Metastatic Non-Small-Cell Lung Cancer (NSCLC) and Study Design of ADXS-504 Trial in Early Prostate Cancer at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting
Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients with prior disease progression on KEYTRUDA ® (pembrolizumab)
3 Hot Penny Stocks That Retail Traders Are Watching Right Now
Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Penny Stocks to Buy From TikTok? 3 That Investors Are Watching
These penny stocks are popular on TikTok, are they on your watchlist? The post Top Penny Stocks to Buy From TikTok?
6 of the Hottest Stocks to Pick Up for Less Than $1
These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. The post 6 of the Hottest Stocks to Pick Up for Less Than $1 appeared first on InvestorPlace.
Best Penny Stocks to Buy Next Month? 3 You Need to Know About
Which penny stocks are on your November watchlist? The post Best Penny Stocks to Buy Next Month?
Top Trending Penny Stocks to Watch Next Month
With so many trending penny stocks to buy, which small caps are you watching? The post Top Trending Penny Stocks to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now
These trending penny stocks could be worth adding to your October watchlist, here's why The post 3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Biotech Penny Stocks to Watch With High Volume Right Now
Are these high volume biotech penny stocks worth adding to your watchlist right now? The post Top Biotech Penny Stocks to Watch With High Volume Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Tech Penny Stocks to Watch During the Market Crash
Can tech penny stocks perform well amidst today's stock market crash? The post 3 Tech Penny Stocks to Watch During the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hot Penny Stocks to Add to Your September Watchlist
Why investors are watching these 3 penny stocks right now The post Hot Penny Stocks to Add to Your September Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
ADXS Financial details
ADXS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-10-31
Metric | History | 2018-10-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-10-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 141.21 | 0.27 | 0.33 | 2.01 | 0.14 | |
Net income per share | -1.55K | -2.07 | -34.71 | -11.07 | -7.9 | |
Operating cash flow per share | -1.45K | -1.74 | -28.77 | -9.57 | -8.4 | |
Free cash flow per share | -1.51K | -1.9 | -29.75 | -9.85 | -8.51 | |
Cash per share | 1.03K | 1.95 | 33.02 | 25.79 | 13.86 | |
Book value per share | 560.17 | 1.68 | 39.58 | 24.1 | 12.99 | |
Tangible book value per share | 447.49 | 1.68 | 35.3 | 22.02 | 12.93 | |
Share holders equity per share | 560.17 | 1.68 | 39.58 | 24.1 | 12.99 | |
Interest debt per share | 58.81 | 0.03 | 7.89 | 0.19 | 0.01 | |
Market cap | 29.2M | 588.78M | 21.28M | 20.09M | 3.38M | |
Enterprise value | -14.95M | 572.36M | 2.11M | -21.48M | -21.81M | |
P/E ratio | -0.44 | -33.09 | -0.8 | -1.12 | -0.24 | |
Price to sales ratio | 4.82 | 252.26 | 84.09 | 6.2 | 13.53 | |
POCF ratio | -0.47 | -39.38 | -0.97 | -1.3 | -0.22 | |
PFCF ratio | -0.45 | -36.17 | -0.94 | -1.26 | -0.22 | |
P/B Ratio | 1.21 | 40.74 | 0.7 | 0.52 | 0.14 | |
PTB ratio | 1.21 | 40.74 | 0.7 | 0.52 | 0.14 | |
EV to sales | -2.46 | 245.23 | 8.36 | -6.63 | -87.25 | |
Enterprise value over EBITDA | 0.21 | -32.59 | -0.09 | 1.14 | 1.38 | |
EV to operating cash flow | 0.24 | -38.28 | -0.1 | 1.39 | 1.43 | |
EV to free cash flow | 0.23 | -35.16 | -0.09 | 1.35 | 1.41 | |
Earnings yield | -2.28 | -0.03 | -1.24 | -0.89 | -4.24 | |
Free cash flow yield | -2.23 | -0.03 | -1.07 | -0.79 | -4.58 | |
Debt to equity | 0.1 | 0.02 | 0.2 | 0 | 0 | |
Debt to assets | 0.04 | 0.01 | 0.16 | 0 | 0 | |
Net debt to EBITDA | 0.61 | 0.94 | 0.79 | 2.22 | 1.6 | |
Current ratio | 2.21 | 3.34 | 8.46 | 5.49 | 11.18 | |
Interest coverage | 0 | 0 | 0 | -72.25 | 0 | |
Income quality | 0.93 | 0.84 | 0.83 | 0.86 | 1.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.21 | 1.86 | 43.83 | 3.54 | 35.56 | |
Research and developement to revenue | 9.4 | 6.18 | 61.71 | 3.26 | 30.43 | |
Intangibles to total assets | 0.08 | 0 | 0.08 | 0.07 | 0 | |
Capex to operating cash flow | 0.05 | 0.09 | 0.03 | 0.03 | 0.01 | |
Capex to revenue | -0.47 | -0.57 | -2.96 | -0.14 | -0.8 | |
Capex to depreciation | -1.89 | -8.87 | -0.38 | -0.46 | -0.64 | |
Stock based compensation to revenue | 1.15 | 0.31 | 3.53 | 0.17 | 0.39 | |
Graham number | 4.42K | 8.86 | 175.81 | 77.47 | 48.04 | |
ROIC | -2.65 | -1.2 | -0.63 | -0.48 | -0.68 | |
Return on tangible assets | -1.16 | -0.89 | -0.75 | -0.41 | -0.56 | |
Graham Net | 138 | 1.34 | 23.41 | 21 | 12.59 | |
Working capital | 27.59M | 12.39M | 24.56M | 35.38M | 23.46M | |
Tangible asset value | 19.21M | 14.45M | 26.92M | 35.53M | 23.52M | |
Net current asset value | 12.25M | 12.09M | 19.51M | 35.37M | 23.46M | |
Invested capital | 0.1 | 0.02 | 0.2 | 0 | 0 | |
Average receivables | 2.23M | 234.5K | 469K | 575K | 340.5K | |
Average payables | 8.62M | 6.11M | 2M | 1.67M | 1.14M | |
Average inventory | 0 | 41.5K | 711K | 329K | -340.5K | |
Days sales outstanding | 0 | 73.34 | 676.62 | 76.72 | 0 | |
Days payables outstanding | 0 | 829.98 | 307.05 | 221.97 | 25.57 | |
Days of inventory on hand | 0 | 23.58 | 380.34 | -67.03 | 0 | |
Receivables turnover | 0 | 4.98 | 0.54 | 4.76 | 0 | |
Payables turnover | 0 | 0.44 | 1.19 | 1.64 | 14.27 | |
Inventory turnover | 0 | 15.48 | 0.96 | -5.44 | 0 | |
ROE | -2.77 | -1.23 | -0.88 | -0.46 | -0.61 | |
Capex per share | -66.17 | -0.16 | -0.98 | -0.29 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-07-31 | 2022-10-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 0.14 | 0 | 0 | 0 | |
Net income per share | -3.65 | -2.73 | -1.67 | -1.82 | -1.53 | |
Operating cash flow per share | -2.12 | -1.64 | -1.53 | 0 | -1.46 | |
Free cash flow per share | -2.15 | -1.53 | -1.53 | 0 | -1.46 | |
Cash per share | 15.49 | 13.88 | 3.82 | 1.48 | 0.44 | |
Book value per share | 15.51 | 13.01 | 2.2 | 0.21 | -1.3 | |
Tangible book value per share | 15.41 | 12.95 | 2.17 | 0.19 | -1.33 | |
Share holders equity per share | 15.51 | 13.01 | 2.2 | 0.21 | -1.3 | |
Interest debt per share | 0.27 | 2.63 | 0.31 | 0.34 | 0.73 | |
Market cap | 6.56M | 3.38M | 5.51M | 4.78M | 4.5M | |
Enterprise value | -21.57M | -21.82M | -9.67M | -760.66K | 5.85M | |
P/E ratio | -0.25 | -0.17 | -0.19 | -0.14 | -0.15 | |
Price to sales ratio | 172.69 | 13.51 | 1.38K | 530.7 | 0 | |
POCF ratio | -1.7 | -1.13 | -0.82 | 0 | -0.64 | |
PFCF ratio | -1.68 | -1.22 | -0.82 | 0 | -0.64 | |
P/B Ratio | 0.23 | 0.14 | 0.57 | 4.73 | -0.72 | |
PTB ratio | 0.23 | 0.14 | 0.57 | 4.73 | -0.72 | |
EV to sales | -567.6 | -87.27 | -2.42K | -84.52 | 0 | |
Enterprise value over EBITDA | 14.68 | 4.46 | 0.82 | 0.09 | -0.83 | |
EV to operating cash flow | 5.6 | 7.33 | 1.43 | 0 | -0.84 | |
EV to free cash flow | 5.51 | 7.86 | 1.43 | 0 | -0.84 | |
Earnings yield | -1.01 | -1.47 | -1.34 | -1.82 | -1.63 | |
Free cash flow yield | -0.6 | -0.82 | -1.22 | 0 | -1.55 | |
Debt to equity | 0.02 | 0.02 | 0.17 | 1.53 | -0.56 | |
Debt to assets | 0.01 | 0.02 | 0.08 | 0.13 | 0.5 | |
Net debt to EBITDA | 19.15 | 5.16 | 1.28 | 0.65 | -0.19 | |
Current ratio | 15.64 | 11.18 | 1.86 | 1.13 | 0.53 | |
Interest coverage | -145.82 | -1.11 | 39.43 | -98.67 | 0 | |
Income quality | 0.55 | 0.65 | 0.92 | 0 | 0.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 54.03 | 10.24 | 1.15K | 307 | 0 | |
Research and developement to revenue | 58.76 | 8.98 | 1.82K | 635.89 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0.01 | 0.01 | 0.02 | |
Capex to operating cash flow | 0.02 | -0.07 | 0 | 0 | 0 | |
Capex to revenue | -1.74 | 0.8 | 0 | 0 | 0 | |
Capex to depreciation | -0.75 | 5.29 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.66 | 0.09 | 296.5 | 0 | 0 | |
Graham number | 35.69 | 28.29 | 9.09 | 2.94 | 6.71 | |
ROIC | -0.24 | -0.22 | -0.58 | -2.1 | 5.33 | |
Return on tangible assets | -0.22 | -0.19 | -0.35 | -0.72 | -1.07 | |
Graham Net | 14.47 | 12.63 | 1.27 | -0.85 | -2.32 | |
Working capital | 27.91M | 23.46M | 8.43M | 1.13M | -3.98M | |
Tangible asset value | 28.01M | 23.52M | 9.55M | 894K | -6.35M | |
Net current asset value | 27.91M | 23.46M | 6.94M | -1.59M | -8.67M | |
Invested capital | 0.02 | 0.02 | 0.17 | 1.53 | -0.56 | |
Average receivables | 450K | 195.5K | 0 | 2K | 0 | |
Average payables | 1M | 1.06M | 0 | 4.28M | 4.74M | |
Average inventory | -450K | -195.5K | 0 | 54K | 0 | |
Days sales outstanding | 620.53 | 46.44 | 90 | 0 | 0 | |
Days payables outstanding | 2.23K | 1.16K | 93.15K | 44.2K | 63.81 | |
Days of inventory on hand | -620.53 | -127.58 | 2.43K | 0 | 0 | |
Receivables turnover | 0.15 | 1.94 | 1 | 0 | 0 | |
Payables turnover | 0.04 | 0.08 | 0 | 0 | 1.41 | |
Inventory turnover | -0.15 | -0.71 | 0.04 | 0 | 0 | |
ROE | -0.24 | -0.21 | -0.76 | -8.62 | 1.18 | |
Capex per share | -0.04 | 0.11 | 0 | 0 | 0 |
ADXS Frequently Asked Questions
What is Advaxis, Inc. stock symbol ?
Advaxis, Inc. is a US stock , located in Monmouth junction of Nj and trading under the symbol ADXS
What is Advaxis, Inc. stock quote today ?
Advaxis, Inc. stock price is $0.64 today.
Is Advaxis, Inc. stock public?
Yes, Advaxis, Inc. is a publicly traded company.